Simmunome AI Companies
Simmunome creates accurate, comprehensive in silico disease models using multi-omic data to determine the probability of success of a drug. Our clinical trial simulations allow you to de-risk your pipeline, getting you to market faster and reducing your R&D costs.
Connections
Headquarters:
Montreal, Quebec, Canada
Last Funding Type:
Pre-Seed
Last Funding Date:
2020
Employee Number:
1-10
Founded Date:
2016
Estimated Revenue:
$US62.5 billion
Industry:
BioTech & Health Care